Microbial metabolite as icebreaker for immunotherapy.
Cell Metab
; 34(4): 506-507, 2022 04 05.
Article
em En
| MEDLINE
| ID: mdl-35385701
ABSTRACT
Immunotherapy has limited success in triple-negative breast cancer (TNBC). In this issue of Cell Metabolism, Wang et al. found that microbial metabolite TMAO boosts CD8+ T cell-mediated antitumor immunity by inducing pyroptosis in tumor cells, enhancing the efficacy of immunotherapy in TNBC (Wang et al., 2022).
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias de Mama Triplo Negativas
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article